TY - JOUR T1 - Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection JF - medRxiv DO - 10.1101/2020.11.03.20225375 SP - 2020.11.03.20225375 AU - Alejandro Márquez-Salinas AU - Carlos A. Fermín-Martínez AU - Neftalí Eduardo Antonio-Villa AU - Arsenio Vargas-Vázquez AU - Enrique C. Guerra AU - Alejandro Campos-Muñoz AU - Lilian Zavala-Romero AU - Roopa Mehta AU - Jessica Paola Bahena-López AU - Edgar Ortiz-Brizuela AU - María Fernanda González-Lara AU - Carla M. Roman-Montes AU - Bernardo A. Martinez-Guerra AU - Alfredo Ponce de Leon AU - José Sifuentes-Osornio AU - Luis Miguel Gutiérrez-Robledo AU - Carlos A. Aguilar-Salinas AU - Omar Yaxmehen Bello-Chavolla Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/24/2020.11.03.20225375.abstract N2 - INTRODUCTION Chronological age (CA) is a predictor of adverse COVID-19 outcomes; however, CA alone does not capture individual responses to SARS-CoV-2 infection. Here, we evaluated the influence of aging metrics PhenoAge and PhenoAgeAccel to predict adverse COVID-19 outcomes. Furthermore, we sought to model adaptive metabolic and inflammatory responses to severe SARS-CoV-2 infection using individual PhenoAge components.METHODS In this retrospective cohort study, we assessed cases admitted to a COVID-19 reference center in Mexico City. PhenoAge and PhenoAgeAccel were estimated using laboratory values at admission. Cox proportional hazards models were fitted to estimate risk for COVID-19 lethality and adverse outcomes (ICU admission, intubation, or death). To explore reproducible patterns which model adaptive responses to SARS-CoV-2 infection, we used k-means clustering using PhenoAge/PhenoAccelAge components.RESULTS We included 1068 subjects of whom 401 presented critical illness and 204 died. PhenoAge was a better predictor of adverse outcomes and lethality compared to CA and SpO2 and its predictive capacity was sustained for all age groups. Patients with responses associated to PhenoAgeAccel>0 had higher risk of death and critical illness compared to those with lower values (log-rank p<0.001). Using unsupervised clustering we identified four adaptive responses to SARS-CoV-2 infection: 1) Inflammaging associated with CA, 2) metabolic dysfunction associated with cardio-metabolic comorbidities, 3) unfavorable hematological response, and 4) response associated with favorable outcomes.CONCLUSIONS Adaptive responses related to accelerated aging metrics are linked to adverse COVID-19 outcomes and have unique and distinguishable features. PhenoAge is a better predictor of adverse outcomes compared to CA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All proceedings were approved by the INCMNSZ Research and Ethics Committee, written informed consent was waived due to the observational nature of the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from the Institutional Data Access Ethics Committee (contact via the corresponding author) for researchers who meet the criteria for access to confidential data. Code for all statistical analyses is available at http://github.com/oyaxbell/covid_phenoage. https://github.com/oyaxbell/covid_phenoage ER -